HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.

12th Edition of Global Insight Conference on

Breast Cancer (GICBC-2025)

Jul 07 - 08, 2025 at Vienna, Austria (Hybrid Event)

Vienna, Austria (Hybrid Event)
+1-408-465-0048
breastcancer@innovinc.org
  • Late-Breaking Abstracts Still Welcome – Now Due by June 19!
  • Last Chance! Spot Registration Now Live
  • Home
  • Brochure
  • Scientific Committee
  • Speakers
  • Agenda
  • Venue
  • Contact
  • Submit Abstract
  • Register
  • slider-home
  • slider-home



See You In:




About Conference

After the grand success of Eleven editions of breast cancer conferences, we solicit your gracious presence at the “12th Global Insight Conference on Breast Cancer" (GICBC-2025) which will be conducted during July 07-08, 2025 as a hybrid event at Vienna, Austria and virtually. The conference will emphasize the theme “Novel Discoveries in Breast Cancer Research & Treatment”.

Breast cancer represents a complicated family of diseases for which detection, diagnosis, and multimodal management strategies are continually evolving. With each lesson learned about the biology of these diseases, and with each improvement to the standards of care, new questions, challenges, and controversies arise.

The scientific programame varies from plenaries, symposia, interactive sessions, pre-congress workshops, joint symposia, poster sessions, and free paper presentations. Our guests will be invited to numerous lectures, meetings, poster presentations, and Exhibitors. We will also discuss organizational issues, with a particular focus on complex approaches for the treatment of Breast Cancer.

Innovinc International Conferences are powered by knowledge, experience, and amazing people and have managed to become one of the leading B2B event organizers. By gathering expert speakers and leading professionals and providing them with strategic knowledge and growth opportunities, our goal is to always focus on innovative trends, cover the most up-to-date topics, and work with top industry minds to prepare and execute high-quality premier events. Our mission is to organize conferences, publish high-quality conference proceedings, and provide services to scientists and young researchers on recent research updates in all fields.

The important benefits of attending this conference includes:

  • Network with colleagues and thought leaders
  • Ask world-renowned experts your important questions
  • Apply state-of-the-art therapies and strategies in your practice
  • Gain expert perspectives and clarity on areas of clinical uncertainty and controversy
  • Improve the evidence-based, patient-centered care you provide to your patients

The organizing team of GICBC-2025 warmly welcomes you to join us in Vienna, Austria (Hybrid Event) on July 07-08, 2025. Do not hesitate and click the "Register" button on the top of the screen to register for attending the GICBC-2025.

Target Audience: 
This conference is intended for medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.

Join us at GICBC-2025 to learn about the latest research updates in Breast Cancer field.

For further information, please feel free to contact me at breastcancer@innovinc.org or reach me Tel: +1-408-465-0048; WhatsApp number +1-408-352-1010

Scientific Sessions

  • Biology & Pathology of Breast Cancer
  • Screening and Imaging
  • Molecular Biology and Genetics of Breast Cancer
  • Immunotherapy in Breast Cancer
  • Prevention & Diagnosis
  • Adjuvant & Neoadjuvant Therapy
  • Innovations in Breast Cancer Diagnosis
  • Triple-Negative Breast Cancer
  • HER2-Positive Breast Cancer
  • Ductal carcinoma and lobular carcinoma
  • Radiotherapy
  • Biomarkers & Risk Factors
  • Targeted Therapy
  • Advancements in Chemotherapy and Combination Therapies
  • Metastatic Breast Cancer
  • Clinical Trials and Translational Research
  • Breast Reconstruction Surgery
  • Novel Therapies and Future Directions

Important Key Dates

23 May 2025

Standard Registration Deadline

19 June 2025

Late-Breaking Abstracts Still Welcome – Now Due by June 19!

12 December 2024

Early Bird Registration Deadline

Keynote Talks/Plenary Talks

  • Daping Fan

    University of South Carolina
    USA

  • Dipanjan Pan

    Pan Dipanjan
    USA

  • Stephen Jack Beebe

    Old Dominion University
    USA

  • Maged Hussien

    Norfolk and Norwich University hospital
    united kingdom

  • Jukka H. Meurman

    University of Helsinki and Helsinki University
    Finland

  • Marylin Dans

    Luminous Global Tech
    USA

WHO'S SPEAKING?

  • Izabela Mlynarczuk

    Warsaw Medical University, Poland

  • Richard Baird

    University of Cambridge, united kingdom

  • Zhenggui Du

    West China Hospital of Sichuan University, China

  • Aina Johnsson

    Karolinska Institutet, Sweden

  • Lei Duan

    Rush University Medical Center, USA

  • Jessica Burgers

    Holy Cross Health, USA

  • Hanna Romanska Knight

    Medical University of Lodz, Poland

  • Buket Barkana

    The University of Akron, USA

  • Tsung Chun Huang

    China Medical University Hospital, Taiwan

  • Sang Jun Han

    Baylor College of Medicine, USA

  • Daping Fan

    University of South Carolina, USA

  • Tanya W. Moseley

    The University of Texas MD Anderson Cancer Center, USA

  • Marc Ong Weijie

    Khoo Teck Puat Hospital, Singapor

  • Zhixiong Jim Xiao

    Sichuan University, China

  • Halina Abramczyk

    Lodz University of Technology, Poland

  • Qi Wang

    University of East Anglia, united kingdom

  • Jahnvi Vijay

    Rajiv Gandhi University of Health Sciences, India

  • Mohammed Alzahrani

    Imam Mohammad Bin Saud Islamic University, Saudi Arabia

  • Haewook Jang

    Meteorbiotech, South Korea

  • Nan-Haw Chow

    China Medical University Hospital, Taiwan

  • Amit K. Tiwari

    University of Arkansas for Medical Sciences, AR, USA

  • Harnoor Singh

    University of Texas at Houston, USA

  • Amna Mehmood

    Martin Luther University Halle-Wittenberg, Germany

  • Idit Shachar

    Systems Immunology, Weizmannn Institute of Science, Israel

  • Sohidul Islam

    Academy of Scientific and Innovative Research, India

  • Howard R Petty

    Predictoma, Inc., USA

  • Tapasree Roy Sarkar

    Texas A & M University, USA

  • Wenzhe Si

    Peking University Third Hospital, China

  • Dorota Lukasiewicz-Smietanska

    National Research Institute, Poland

  • Vagif Galandarov

    Azerbaijan Medical University, Azerbaijan

  • Syeda Zakia Hossain

    The University of Sydney, Camperdown, Australia

  • Laura Conti

    University of Torino, Italy

  • Azam Najaf Kouchak

    Michigan State University, USA

  • Zhangyong Hong

    Nankai University, China

  • Herbert Schneckenburger

    Aalen University, Germany

  • Aili Saiding

    Guangyuan Central Hospital, China

  • Harish Chander

    National Institute of Biologicals, India

  • Reena Jassal

    Punjabi University, India

  • Gábor Somlyai

    HYD LLC for Cancer Research and Drug Development , Hungary

  • Paola Poma

    University of Palermo, Italy

  • Manjiri Bakre

    OncoStem Diagnostics Pvt Ltd, India

  • Hye Jin Park

    Kangwon National University, South Korea

  • Jassim Al-Hassan

    Abdullah AlSalem University, Kuwait

  • Saad Alomar

    College of Medicine-University of Basra, Iraq

  • Columba De La Parra

    LEHMAN COLLEGE- City University of New York (CUNY), USA

  • Rizzo Monica

    Emory University School of Medicine, USA

  • Hardik J Pandya

    Indian Institute of Science, India

  • Amy S. Yee

    Tufts University School of Medicine, USA

  • Jamie Spoont

    University of Miami-Miller School of Medicine, USA

  • Chiaching Yu

    Taipei City Hospital, Yangming Branch, Taipei, Taiwan

  • Jung Su Yon

    University of California, USA

  • YuTe Liu

    Chung Shan Medical University Medical Clinical, Taiwan

  • Bala Gur Dedeoglu

    Ankara University, Turkey

  • Jacqueline Tsai

    Stanford University School of Medicine, USA

  • Yaoshi Wu

    AstraZeneca, USA

  • Huiping Chen

    Sun Yat Sen University, China

  • Candace Howard-Claudio

    University of Mississippi Medical Center, USA

  • Haiyan Li

    The Sixth Affiliated Hospital of Sun Yat-sen University, China

  • Wenfeng Zeng

    Sun Yat-Sen University, China

  • Yali Xu

    Peking Union Medical College Hospital, China

  • Nur Qodir

    University of Sriwijaya, Indonesia

  • Elisabetta Panza

    University of Naples Federico, Italy

  • Atziri Corin Chavez Alvarez

    Inserm-Université Clermont-Auvergne, France

  • Stanley Lipkowitz

    National Cancer Institute, USA

  • Mohammed Hassan A Obaidan

    University College Dublin, Saudi Arabia

  • Carmen Miano

    University of Bologna, Italy

  • View All Speakers

    Speaker (In-Person)

    € 799

    Delegate

    € 899

    YoungResearcher/Poster Presentation

    € 599

    Virtual Speaker (Through ZOOM)

    € 299

    HURRY UP! ONLY 67 SEATS REMAINING CURRENTLY…

    Don t Miss This Amazing Conference And Opportunities

    Register me

    Testimonials




    Xinyu Zheng

    First Hospital of China Medical University, China

    This is a great academic conference, a wonderful experience, thank you for everything you have done. hope to see you next time,

    Bharati Pandya

    All India Institute of Medical Sciences, India

    It was really a fabulous experience, thanks to your guidance.

    Hanna M. Romanska

    Medical University of Lodz, Poland

    It was a very pleasurable and worthy experience.

    Luana Conte

    University of Salento, Italy

    It was a very interesting and powerful meeting.

    Young Choi

    Yale School of Medicine, USA

    The meeting was interesting and speeches were good.

    Elena Quaglino

    University of Torino, Italy

    It has been a pleasure to be part of this meeting.

    Christina M. Dieli-Conwright

    Dana-Farber Cancer Institute, Italy

    Thank you so much for the opportunity to present. it was a great meeting.

    Buket Barkana

    The University of Akron, USA

    Thank you very much for the great organization. It was a great organization for networking and starting new research collaborations. I will put next edition event on my calendar.

    Past Conference Gallery

    • Fashion model
      Breast Cancer Conference 2024 at Prague, Czech Republic
    • Fashion model
      Breast Cancer Conference 2024 at Prague, Czech Republic
    • Fashion model
      Breast Cancer Conference 2024 at Prague, Czech Republic
    • Fashion model
      Breast Cancer Conference 2024 at Prague, Czech Republic
    • Fashion model
      Breast Cancer Conference 2024 at Prague, Czech Republic
    • Fashion model
      Breast Cancer Conference 2024 at Prague, Czech Republic
    • Fashion model
      Breast Cancer Conference 2024 at Prague, Czech Republic
    • Fashion model
      Breast Cancer Conference 2024 at Prague, Czech Republic
    View More

    Promote Partners

    Contact Information

    +1-408-465-0048
    breastcancer@innovinc.org
    +1-408-352-1010

    Locate US

    5201 Great America Pkwy #320, Santa Clara, CA 95054, United States

    Keep me Updated..!


    Copyrights © 2020-21 Innovinc International, All Rights Reserved